Under this new initiative, Medicare beneficiaries can get the tests at no cost from eligible pharmacies and other entities they do not need to pay for the tests and submit for reimbursement. In April 2022, the Biden Administration finalized an initiative providing for Medicare coverage of up to 8 at-home COVID tests per month for Medicare beneficiaries with Part B, including beneficiaries in traditional Medicare and Medicare Advantage. Does Medicare cover testing for COVID-19? These FAQs review current policies for Medicare coverage and costs associated with testing and treatment for COVID-19, including regulatory changes issued by CMS since the declaration of the public health emergency ( first issued on Januand most recently renewed in January 2022), and legislative changes in three bills enacted since the start of the pandemic: the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, enacted on Ma(Public Law 116-123) the Families First Coronavirus Response Act, enacted on Ma(Public Law 116-127) and the Coronavirus Aid, Relief, and Economic Security (CARES) Act, enacted on Ma(Public Law 116-136).
According to data from the Centers for Medicare & Medicaid Services (CMS), through November 20, 2021, there have been over 6 million cases of COVID-19 among Medicare beneficiaries and 1.6 million hospitalizations.
Diagnosis of COVID-19 is confirmed through testing, and treatment varies based on the severity of illness. COVID-19 is an infectious disease which currently has no cure, although several therapeutics and vaccines have been or are being developed.
Due to their older age and higher likelihood of having serious medical conditions than younger adults, virtually all Medicare beneficiaries are at greater risk of becoming seriously ill if they are infected with SARS-CoV-2, the coronavirus that causes COVID-19. More than 60 million people ages 65 and older and younger adults with long-term disabilities are covered by Medicare.
0 kommentar(er)
